Search clinical trials for: seasonal depression winter blues winter depression

Total 12964 results

Philips Respironics

Completed

30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder (SAD)

Seasonal Affective Disorder

United States
GlaxoSmithKline

Completed

Seasonal Affective Depression (SAD) Study

Depressive Disorder

United States
GlaxoSmithKline

Completed

Prevention of Seasonal Affective Disorder

Seasonal Affective Disorder

United States, Canada
University of Pittsburgh

Completed

Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive Disorder (Season605)

Seasonal Affective Disorder

United States
Centre Hospitalier Universitaire de la Réunion

Completed

Health Consequences of Wintering in the French Southern and Antarctic Territories (MediTAAF)

Endocrine System Diseases | Sleep Disorder | Environmental Exposure | Immunologic Activity Alteration | Winter Depression

Réunion
University of Vermont
University of Pittsburgh; University of Maryland School of Medicine

Active, not recruiting

Optimizing Long-Term Outcomes for Winter Depression With CBT-SAD and Light Therapy

Seasonal Affective Disorder

United States
University of Vermont
National Institute of Mental Health (NIMH)

Completed

Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence

Seasonal Affective Disorder (SAD) | Winter Depression | Major Depressive Disorder, Recurrent, With Seasonal Pattern

United States
University of Maryland, Baltimore
National Institute of Mental Health (NIMH)

Completed

Predicting Effectiveness of Light Treatment for Winter Seasonal Affective Disorder

Depression
National Institute of Mental Health (NIMH)

Completed

Clinical Trial of Propranolol for Seasonal Affective Disorder

Healthy | Seasonal Affective Disorder

United States
Thomas Jefferson University
Apollo Health Systems

Completed

Research Study of Treatment for Winter Depression With Different Colors of Light

Seasonal Affective Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)

Depression | Mood Disorders | Seasonal Affective Disorder

United States
Yale University
University of British Columbia; McGill University Health Centre/Research Institute... and other collaborators

Completed

A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)

Seasonal Affective Disorder

United States, Canada, Netherlands
Connie Thuree Nielsen, consultant, MD, ph.d

Completed

The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff (D3-vit-SAD)

Mental Health | Seasonal Affective Disorder | Vitamin D3 | Dietary Supplement

Denmark
University Medical Center Groningen

Completed

Blue Enriched Versus Standard Light Treatment for Seasonal Affective Disorder(SAD)

Seasonal Affective Disorder

Netherlands
Gilgamesh Pharmaceuticals

Recruiting

A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD

Major Depressive Disorder

United Kingdom
Gilgamesh Pharmaceuticals

Recruiting

A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD

Major Depressive Disorder

United Kingdom
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY BD)

Bipolar Depression

Austria, Germany, Italy, Spain, United Kingdom
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY MDD)

Major Depressive Disorder | Treatment Resistant Depression

Austria, Germany, Italy, Spain, United Kingdom
Dr. Inge Winter
Universität Münster

Not yet recruiting

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure (INTENSIFY)

Bipolar Depression | Major Depressive Disorder | Schizophrenia and Related Disorders

Israel
Relmada Therapeutics, Inc.

Recruiting

A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) (RELIANCE-II)

Depression | Major Depressive Disorder

United States
VA Office of Research and Development
Thomas Jefferson University

Active, not recruiting

ACTIVE: Activity Therapy to Increase Veteran Engagement (ACTIVE)

Traumatic Brain Injury

United States
Rahel Naef
Swiss National Science Foundation

Active, not recruiting

Family Support Intervention in Intensive Care Units (FICUS)

Quality of Life | Posttraumatic Stress Disorder | Depression, Anxiety | Postintensive Care Syndrome | Family Members | Family Dynamics

Switzerland
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Treatment Resistant Depression

United States
Neurocrine Biosciences

Completed

Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD (TERPSIS)

Anhedonia | Major Depressive Disorder

United States, Puerto Rico
Northwell Health
Winterlight Labs

Completed

Ascertaining Diagnosis Classification With Elicited Speech (ACES)

Personality Disorders | Depressive Disorder | Schizophrenia Spectrum and Other Psychotic Disorders | Anxiety Disorders | Bipolar and Related Disorders | Attention Deficit Hyperactivity Disorder

United States
University of Zurich
Medical University of Graz; Charite University, Berlin, Germany; Cantonal Hospital... and other collaborators

Completed

Quality of Life in Endometriosis - a Case Control Study

Depression | Quality of Life | Pain | Infertility | Endometriosis | Anxiety | Sexuality

Switzerland
PharmaNeuroBoost N.V.

Completed

Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Canada
Shire

Terminated

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

Major Depressive Disorder

United States, Spain, Germany, Puerto Rico, Canada, Estonia, South Africa, Czechia, Finland, Chile, Hungary, Mexico, Poland, Romania
Shire

Completed

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States, Chile, Australia, Argentina, United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

Bipolar Disorder

United States
Novartis

Completed

A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Alkermes, Inc.

Completed

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study

Major Depressive Disorder

United States, Canada, Germany, Puerto Rico
Pfizer

Completed

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Major Depressive Disorder

United States, Mexico
Alkermes, Inc.

Completed

A Long-Term Safety Study of ALKS 5461

Major Depressive Disorder

United States, Canada, Germany, Puerto Rico, Bulgaria, Australia, Poland, Hungary
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) (Orion)

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, France, Poland, Russian Federation, Romania, Ukraine, Germany, Hungary, Slovakia, Serbia, Canada
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
GlaxoSmithKline

Terminated

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (Orvepitant MDD)

Depressive Disorder

United States, Canada
Pfizer

Completed

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Major Depressive Disorder

United States, Mexico
Sprout Pharmaceuticals, Inc

Terminated

12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress

Depression | Sexual Dysfunctions, Psychological

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) (Polaris)

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Russian Federation, Hungary, Romania, Ukraine, Canada, Germany
Forest Laboratories

Completed

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Finland, Germany, Romania, Russian Federation, Serbia, Ukraine
GlaxoSmithKline

Completed

Study Of GW679769 In Major Depressive Disorder

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States, Canada
GlaxoSmithKline

Completed

An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

Depressive Disorder, Major

United States
Forest Laboratories

Completed

Safety and Efficacy of Vilazodone in Major Depressive Disorder (VLZ-MD-01)

Major Depressive Disorder

United States
Somerset Pharmaceuticals

Completed

Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression

Major Depressive Disorder

United States
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Major Depressive Disorder

United States
Cephalon

Completed

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

Obstructive Sleep Apnea | Major Depressive Disorder | Sleep Disorders | Dysthymic Disorder

United States
AstraZeneca

Completed

Seroquel in Bipolar Depression Versus SSRI (EMBOLDEN II)

Depression | Bipolar Disorder | Bipolar Depression

United States, Peru, South Africa, Turkey, Romania, Australia, Chile, Greece, Mexico, Colombia, Costa Rica

Search clinical trials for: seasonal depression winter blues winter depression

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations